Security key
22663K107
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX)
CUSIP: 22663K107
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 51,456,378
- Total 13F value
- $1,010,816,996
- Share change
- +729,635
- SEC-reported price per share
- $19.64
- Number of holders
- 118
- Value change
- +$16,147,822
- Number of buys
- 65
- Number of sells
- 39
- Shares outstanding
- 105,000,216
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
118
Top holders
10
CRNX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Crinetics Pharmaceuticals, Inc. SEC filings
Crinetics Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22663K107
Recent filing periods:
Ownership snapshot
Top reported holders of CRNX - Crinetics Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
DRIEHAUS CAPITAL MANAGEME...
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
3/4/5
Lead comparable stake: 5.2%
Showing 1-6 of 15 holder rows.
Quick read
DRIEHAUS CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 5.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens DRIEHAUS CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
DRIEHAUS CAPITAL MANAGEMENT LLC
5.2%
PERCEPTIVE ADVISORS LLC
5.1%
BlackRock Finance, Inc.
3.6%
BVF INC/IL
3.5%
ORBIMED ADVISORS LLC
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
Company
|
5.2%
|
$102,099,000
5,474,459 shares
|
— | 30 Jun 2022 |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
10%+ Owner · Company
|
5.1%
from 13F
|
$200,336,855
5,321,032 shares
|
— | 18 Apr 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
3.6%
|
$70,675,000
3,789,483 shares
|
— | 30 Jun 2022 |
| BVF INC/IL |
13F
Company
|
3.5%
|
$68,612,000
3,678,947 shares
|
— | 30 Jun 2022 |
| ORBIMED ADVISORS LLC |
13F
Company
|
3%
|
$59,622,000
3,196,876 shares
|
— | 30 Jun 2022 |
| FMR LLC |
13F
Company
|
2.8%
|
$55,707,000
2,987,020 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
118
Shares
51,456,378
Rows available
118
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
109
Q3 2022 holders
118
Holder diff
9
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend